Elevance Health, Inc. reaffirmed its full year 2026 shareholders' earnings guidance of at least $19.85 per diluted share, which includes approximately $6.90 per diluted share of net unfavorable items. Excluding these items, the company expects adjusted shareholders' earnings to be at least $26.75 per diluted share. Additionally, the company reaffirmed its full year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points. Elevance Health, Inc. is a healthcare company that provides health insurance and pharmacy services.
